How volume and concentration requirements are reshaping device selection.
Phillips Medisize’s Tony Bedford considers how the rise in biologic formulations together with a strong shift towards subcutaneous administration is shaping the drug delivery industry, particularly in relation to large-volume subcutaneous delivery.
